Associated Papers
The relevance of the reference range for EGFR testing in non-small cell lung cancer patients.
Pisapia P et al.
Lung Cancer (amsterdam, Netherlands), 2024
Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma.
Xu T et al.
Theranostics, 2017
Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
Mohar B et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology, 2016
Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer.
Hsiue EH et al.
Expert Review of Molecular Diagnostics, 2016
Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.
Paliogiannis P et al.
Molecular Medicine Reports, 2015
Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.
Wong SQ et al.
British Journal of Cancer, 2015
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.
Stella GM et al.
Journal of Cancer Research and Clinical Oncology, 2013
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing.
Buttitta F et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013
[Discordance of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in non-small cell lung cancer].
Fang Q et al.
Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer, 2011
A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer.
Su Z et al.
The Journal of Molecular Diagnostics : Jmd, 2011
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Toyama T et al.
Bmc Cancer, 2008
Database of somatic mutations in EGFR with analyses revealing indel hotspots but no smoking-associated signature.
Gu D et al.
Human Mutation, 2007
Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.
Sequist LV et al.
The Oncologist, 2007
EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.
Sakaeda T et al.
Pharmaceutical Research, 2005
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
Mu XL et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2005